Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Skye Bioscience, Inc. (SKYE) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Skye Bioscience, Inc. (SKYE), most recent 12 months reported: net loss $50.49M, free cash flow -$38.81M. Latest balance sheet on file: liquid cash $10.06M, total debt $143.05K, net cash $9.92M. From SEC filings. Others in Pharmaceutical Preparations: Rezolute, Inc. · Sagimet Biosciences Inc. · SHUTTLE PHARMACEUTICALS HOLDINGS, INC. · SIONNA THERAPEUTICS, INC. · SELLAS Life Sciences Group, Inc. · Summit Therapeutics Inc. · Semnur Pharmaceuticals, Inc. · SOLIGENIX, INC.

Stock screener

Watchlist